Bromfenac Sodium Patent Expiration
Bromfenac Sodium is Used for managing ocular inflammation, postoperative inflammation, and reducing ocular pain in patients after cataract surgery. It was first introduced by Bausch And Lomb Inc
Bromfenac Sodium Patents
Given below is the list of patents protecting Bromfenac Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prolensa | US9517220 | Bromfenac bioavailability | Nov 11, 2033 | Bausch And Lomb |
| Prolensa | US10085958 | Bromfenac bioavailability | Nov 19, 2032 | Bausch And Lomb |
| Bromsite | US8778999 | Non-steroidal anti-inflammatory ophthalmic compositions | Aug 07, 2029 | Sun Pharm |
| Prolensa | US8129431 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid | Sep 11, 2025 | Bausch And Lomb |
| Prolensa | US8669290 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
Jan 16, 2024
(Expired) | Bausch And Lomb |
| Prolensa | US8754131 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
Jan 16, 2024
(Expired) | Bausch And Lomb |
| Prolensa | US8871813 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
Jan 16, 2024
(Expired) | Bausch And Lomb |
| Prolensa | US8927606 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
Jan 16, 2024
(Expired) | Bausch And Lomb |
| Prolensa | US9144609 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
Jan 16, 2024
(Expired) | Bausch And Lomb |
| Prolensa | US9561277 | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
Jan 16, 2024
(Expired) | Bausch And Lomb |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Bromfenac Sodium's patents.
Latest Legal Activities on Bromfenac Sodium's Patents
Given below is the list recent legal activities going on the following patents of Bromfenac Sodium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 May, 2024 | US9517220 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Mar, 2023 | US9144609(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Jun, 2022 | US8927606 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Mar, 2022 | US10085958 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 Mar, 2022 | US8871813 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Dec, 2021 | US8754131(Litigated) |
| Correspondence Address Change Critical | 30 Aug, 2021 | US10085958 |
| Correspondence Address Change Critical | 30 Aug, 2021 | US9517220 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 06 Aug, 2021 | US8669290 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 04 Jun, 2020 | US9517220 |
Bromfenac Sodium's Family Patents
Explore Our Curated Drug Screens
Bromfenac Sodium Generic API Manufacturers
Several generic applications have been filed for Bromfenac Sodium. The first generic version for Bromfenac Sodium was by Coastal Pharmaceuticals and was approved on May 11, 2011. And the latest generic version is by Amneal Eu Ltd and was approved on Jul 29, 2024.
Given below is the list of companies who have filed for Bromfenac Sodium generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID
(reference standard) | solution/drops | Prescription | OPHTHALMIC | AT2 | Jun 21, 2019 |
| EQ 0.07% ACID | solution/drops | Prescription | OPHTHALMIC | AB | Jul 8, 2024 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.07% ACID | solution/drops | Prescription | OPHTHALMIC | AB | Jul 29, 2024 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
3. AMRING PHARMS
Amring Pharmaceuticals Inc has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Amring Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Discontinued | OPHTHALMIC | N/A | Jan 9, 2013 |
4. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Discontinued | OPHTHALMIC | N/A | Jun 23, 2014 |
| EQ 0.07% ACID | solution/drops | Prescription | OPHTHALMIC | AB | Jul 8, 2024 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Discontinued | OPHTHALMIC | N/A | Feb 10, 2015 |
6. COASTAL PHARMS
Coastal Pharmaceuticals has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Coastal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Discontinued | OPHTHALMIC | N/A | May 11, 2011 |
7. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Prescription | OPHTHALMIC | AT2 | Mar 18, 2022 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
8. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Prescription | OPHTHALMIC | AT2 | Mar 17, 2020 |
9. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Prescription | OPHTHALMIC | AT2 | Aug 15, 2023 |
| EQ 0.07% ACID | solution/drops | Prescription | OPHTHALMIC | AB | Nov 22, 2023 |
| EQ 0.075% ACID | solution/drops | Prescription | OPHTHALMIC | AB | Feb 2, 2024 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
10. RISING
Rising Pharma Holding Inc has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Discontinued | OPHTHALMIC | N/A | Jun 3, 2019 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
11. SENTISS
Sentiss Ag has filed for 1 generic for Bromfenac Sodium. Given below are the details of the strengths of this generic introduced by Sentiss.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09% ACID | solution/drops | Prescription | OPHTHALMIC | AT2 | Jan 22, 2014 |
Manufacturing Plant Locations New
Sentiss's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Sentiss as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||